127 related articles for article (PubMed ID: 1495821)
1. [Methodology of clinical trials in migraine: a rating system].
Tzourio C; Massiou H; Bousser MG
Pathol Biol (Paris); 1992 Apr; 40(4):361-6. PubMed ID: 1495821
[TBL] [Abstract][Full Text] [Related]
2. [Controlled therapeutic trials in migraine: methodology and results].
Baron JC; Bousser MG
Rev Neurol (Paris); 1982; 138(4):279-95. PubMed ID: 6753081
[TBL] [Abstract][Full Text] [Related]
3. Placebo efficacy in childhood and adolescence migraine: an analysis of double-blind and placebo-controlled studies.
Evers S; Marziniak M; Frese A; Gralow I
Cephalalgia; 2009 Apr; 29(4):436-44. PubMed ID: 19170687
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials.
Shuhendler AJ; Lee S; Siu M; Ondovcik S; Lam K; Alabdullatif A; Zhang X; Machado M; Einarson TR
Pharmacotherapy; 2009 Jul; 29(7):784-91. PubMed ID: 19558252
[TBL] [Abstract][Full Text] [Related]
5. Methodology of drug trials in migraine.
Tfelt-Hansen P; Nielsen SL
Funct Neurol; 1986; 1(4):499-502. PubMed ID: 3609877
[TBL] [Abstract][Full Text] [Related]
6. Eletriptan for the acute treatment of migraine in adolescents: results of a double-blind, placebo-controlled trial.
Winner P; Linder SL; Lipton RB; Almas M; Parsons B; Pitman V
Headache; 2007 Apr; 47(4):511-8. PubMed ID: 17445100
[TBL] [Abstract][Full Text] [Related]
7. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
8. Haloperidol in the acute treatment of migraine: a randomized, double-blind, placebo-controlled study.
Honkaniemi J; Liimatainen S; Rainesalo S; Sulavuori S
Headache; 2006 May; 46(5):781-7. PubMed ID: 16643581
[TBL] [Abstract][Full Text] [Related]
9. Early intervention in migraine with sumatriptan tablets 50 mg versus 100 mg: a pooled analysis of data from six clinical trials.
Winner P; Landy S; Richardson M; Ames M
Clin Ther; 2005 Nov; 27(11):1785-94. PubMed ID: 16368449
[TBL] [Abstract][Full Text] [Related]
10. Elimination of migraine-associated nausea in patients treated with rizatriptan orally disintegrating tablet (ODT): a randomized, double-blind, placebo-controlled study.
Freitag F; Taylor FR; Hamid MA; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2008 Mar; 48(3):368-77. PubMed ID: 18047500
[TBL] [Abstract][Full Text] [Related]
11. Intravenous dexamethasone vs placebo as adjunctive therapy to reduce the recurrence rate of acute migraine headaches: a multicenter, double-blinded, placebo-controlled randomized clinical trial.
Donaldson D; Sundermann R; Jackson R; Bastani A
Am J Emerg Med; 2008 Feb; 26(2):124-30. PubMed ID: 18272089
[TBL] [Abstract][Full Text] [Related]
12. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine.
Stensrud P; Sjaastad O
Ups J Med Sci Suppl; 1980; 31():37-40. PubMed ID: 7006182
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
Diener HC
Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous valproic acid for acute migraine.
Frazee LA; Foraker KC
Ann Pharmacother; 2008 Mar; 42(3):403-7. PubMed ID: 18303140
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, speed of action and tolerability of almotriptan in the acute treatment of migraine: pooled individual patient data from four randomized, double-blind, placebo-controlled clinical trials.
Dahlöf CG; Pascual J; Dodick DW; Dowson AJ
Cephalalgia; 2006 Apr; 26(4):400-8. PubMed ID: 16556240
[TBL] [Abstract][Full Text] [Related]
16. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets.
Sheftell FD; Dahlöf CG; Brandes JL; Agosti R; Jones MW; Barrett PS
Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814
[TBL] [Abstract][Full Text] [Related]
17. Headache classification by history has only limited predictive value for headache episodes treated in controlled trials with OTC analgesics.
Diener HC; Pfaffenrath V; Pageler L; Peil H; Aicher B; Lipton RB
Cephalalgia; 2009 Feb; 29(2):188-93. PubMed ID: 18823361
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
[TBL] [Abstract][Full Text] [Related]
19. Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls.
Loder E; Goldstein R; Biondi D
Cephalalgia; 2005 Feb; 25(2):124-31. PubMed ID: 15658949
[TBL] [Abstract][Full Text] [Related]
20. Propranolol and migraine. A clinical trial.
Pita E; Higueras A; Bolaños J; Pérez N; Mundo A
Arch Farmacol Toxicol; 1977 Dec; 3(3):273-8. PubMed ID: 350168
[No Abstract] [Full Text] [Related]
[Next] [New Search]
